Načítá se...
Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: A pilot study
Despite moderate success with pharmacological and behavioral treatments, smoking relapse rates remain high, and many smokers report that smoking cues lead to relapse. Therefore, treatments that target cue reactivity are needed. One candidate for reducing craving is the neuropeptide oxytocin (OT). He...
Uloženo v:
| Vydáno v: | Behav Pharmacol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5089916/ https://ncbi.nlm.nih.gov/pubmed/27661192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FBP.0000000000000260 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|